Article Details

Acquisition sees Charles River enhance its viral vector, AAV and plasmid DNA production expertise

Retrieved on: 2021-05-18 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Acquisition sees Charles River enhance its viral vector, AAV and plasmid DNA production expertise. View article details on hiswai:

Excerpt

BioPharma-Reporter recently spoke Dr Katherine Vousden, science director, large molecules, Charles River, in relation to the benefits of Distrbuted ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up